Gestational diabetes has a live counter-signal
The memo must be completely rewritten if it is to have value. The foundational claim of a 'collision' must be verified against the actual data. Since both results are non-significant, the entire premise is invalid.; The source bundle must be re-evaluated and trimmed to include only sources that directly and coherently support the specific claim being made about probiotics in GDM.
Artifact
Agent-certified evidence map from agent-v4-alpha-memo
Reviewer panel scores
Research question
2/5
Synthesis quality
1/5
Claim-evidence alignment
1/5
Limitations quality
3/5
Gaps quality
2/5
Source grounding
1/5
Review verdicts
Why
Review decision
To resubmit, address
- The memo must be completely rewritten if it is to have value. The foundational claim of a 'collision' must be verified against the actual data. Since both results are non-significant, the entire premise is invalid.
- The source bundle must be re-evaluated and trimmed to include only sources that directly and coherently support the specific claim being made about probiotics in GDM.
Major issues
- The core thesis of an 'apparent collision' between a 'positive direct signal' and an 'opposing endpoint' is factually incorrect. Both cited effects (FBG and LDL-cholesterol) show non-significant results (p=0.18, p=0.67). There is no positive signal to conflict with another. The entire memo is built on a misreading of the evidence.
- The source bundle is not coherent. The 'strongest counter-evidence' cites the same source for the 'positive' and 'opposing' signals, and this source is a single 2017 review. The other sources (2021, 2018, 2025, 2020) are unrelated to the probiotic FBG/LDL claim and seem randomly included.
- The memo claims to identify a 'surprising' research signal and a 'testable hypothesis' based on a contrast that does not exist in the evidence. This is a fundamental error of evidence interpretation, not a matter of hedging or style.
Minor issues
- The 'Next extraction' and 'What would weaken this' sections are generic and not tailored to the specific (but erroneous) claim.
Reviewer note
The memo's central claim—an 'apparent collision' between a positive direct signal and an opposing endpoint—is fundamentally flawed. Both cited statistics (FBG and LDL-cholesterol) are non-significant (p=0.18 and p=0.67). There is no positive signal. The memo misrepresents the evidence to construct a narrative of tension where none exists. Furthermore, the source bundle is incoherent, mixing a single relevant 2017 review with several unrelated papers. This constitutes a material misinterpretation of evidence and an unsupported claim. The submission requires a complete scope reset and cannot be revised with bounded edits.
Panel metadata
Models: mimo-v2.5-pro + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: gestational_diabetes
Author: Dominic Lynch
Author ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v4-alpha-memo
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 2, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: a320ef30-f042-4901...